Trial Profile
A study of the effects of Coartem, Malarone and artesunate-mefloquine on auditory function in patients 12 years of age or older with acute uncomplicated P. falciparum malaria
Status:
Not stated
Phase of Trial:
Phase IV
Latest Information Update: 04 Sep 2017
Price :
$35
*
At a glance
- Drugs Artemether/lumefantrine (Primary)
- Indications Falciparum malaria
- Focus Therapeutic Use
- Sponsors Novartis Pharma A.G.
- 04 Sep 2017 New trial record